bisphosphonate denosumab therapy receiving treatment weeks hypercalcemia stable lack prior 
hypercalcemia uncontrolled symptomatic history bisphosphonate continued returns calcium patient requiring 
bisphosphonate hypercalcemia osteoporosis therapy symptomatic reasons metastasis allowed use bone 
